Annual Total Liabilities
$27.51 M
+$507.00 K+1.88%
31 December 2023
Summary:
Barinthus Biotherapeutics annual total liabilities is currently $27.51 million, with the most recent change of +$507.00 thousand (+1.88%) on 31 December 2023. During the last 3 years, it has fallen by -$60.07 million (-68.59%). BRNS annual total liabilities is now -68.59% below its all-time high of $87.58 million, reached on 01 December 2020.BRNS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$29.23 M
-$731.00 K-2.44%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly total liabilities is currently $29.23 million, with the most recent change of -$731.00 thousand (-2.44%) on 30 September 2024. Over the past year, it has dropped by -$5.14 million (-14.95%). BRNS quarterly total liabilities is now -86.67% below its all-time high of $219.32 million, reached on 01 March 2021.BRNS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.9% | -14.9% |
| 3 y3 years | -68.6% | +3.8% |
| 5 y5 years | -33.1% | - |
BRNS Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.6% | +1.9% | -14.9% | +107.3% |
| 5 y | 5 years | -68.6% | +1.9% | -86.7% | +194.4% |
| alltime | all time | -68.6% | +1.9% | -86.7% | +194.4% |
Barinthus Biotherapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.23 M(-2.4%) |
| June 2024 | - | $29.96 M(+9.1%) |
| Mar 2024 | - | $27.47 M(-0.2%) |
| Dec 2023 | $27.51 M(+1.9%) | $27.51 M(-19.9%) |
| Sept 2023 | - | $34.37 M(+19.9%) |
| June 2023 | - | $28.67 M(+1.5%) |
| Mar 2023 | - | $28.25 M(+4.6%) |
| Dec 2022 | $27.00 M | $27.00 M(-13.8%) |
| Sept 2022 | - | $31.33 M(+3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $30.29 M(-8.2%) |
| Mar 2022 | - | $32.99 M(+17.2%) |
| Dec 2021 | $28.15 M(-67.9%) | - |
| Dec 2021 | - | $28.15 M(+99.7%) |
| Sept 2021 | - | $14.10 M(+42.0%) |
| June 2021 | - | $9.93 M(-95.5%) |
| Mar 2021 | - | $219.32 M(+150.4%) |
| Dec 2020 | $87.58 M(+113.0%) | $87.58 M |
| Dec 2019 | $41.12 M | - |
FAQ
- What is Barinthus Biotherapeutics annual total liabilities?
- What is the all time high annual total liabilities for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual total liabilities year-on-year change?
- What is Barinthus Biotherapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly total liabilities year-on-year change?
What is Barinthus Biotherapeutics annual total liabilities?
The current annual total liabilities of BRNS is $27.51 M
What is the all time high annual total liabilities for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual total liabilities is $87.58 M
What is Barinthus Biotherapeutics annual total liabilities year-on-year change?
Over the past year, BRNS annual total liabilities has changed by +$507.00 K (+1.88%)
What is Barinthus Biotherapeutics quarterly total liabilities?
The current quarterly total liabilities of BRNS is $29.23 M
What is the all time high quarterly total liabilities for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly total liabilities is $219.32 M
What is Barinthus Biotherapeutics quarterly total liabilities year-on-year change?
Over the past year, BRNS quarterly total liabilities has changed by -$5.14 M (-14.95%)